TINN2 is a European research network (Collaborative Project) supported by the European Commission under the Health Cooperation Work Programme of the 7 th Framework Programme.

News & Events


TINN European Survey on the Use of Antibiotics in NICUs

The survey results are now available and the published article has been published.

Please click here to consult it.


MANY THANKS to all the Neonatal Intensive Care Units that dedicated their time to partipate in the TINN2 survey.


Consortium final meeting on 8th October 2015, in Paris, France

The official event of the TINN2 FP7 European Research Project was organised by Inserm-Transfert on 8th October 2015 in Paris (France).

This meeting gathered together all TINN2 partners for presenting and discussing the latest progresses within TINN2 activities, a project on preclinical studies and paediatric investigation plans for children, under the coordination of the French National Institute of Health and Medical Research (Inserm).

European Congress of Clinical Microbiology and Infectious Diseases, London, United Kingdom 31st to 4th April 2012


TINN2 Project was presented on Poster at the ECCMID congress in London, United Kingdom.

Brochure PDF :


Simcyp provides a platform for modelling and simulation of drug absorption, distribution, metabolism and excretion (ADME) in virtual populations. The Simulator is licensed to our Consortium member clients for use in drug discovery and development. Currently, 9 of the top 10 pharmaceutical companies worldwide have access to Simcyp expertise through Consortium membership. The Consortium helps guide scientific development at Simcyp, ensuring that our products continue to meet, and exceed, industry needs. Simcyp maintains strong academic links and our science team conducts internationally recognised cutting-edge research and development. Simcyp also offer sconsultancy services and run education programmes around the world.

Currently 9 out of 10 pharmaceutical companies use the Simcyp platform in their routine in vitro & in vivo extrapolations to simulate clinical studies in adult populations. Some of these companies have access to the Simcyp Paediatrics module as well. The performance of the system in predicting clearance values of 11 drugs has already been published as a scientific report (Johnson et al 2006, Clin Pharmacokintics).


Back to the list of institutions